• Info
  • Insider Ownership

Insider Trading & Ownership of James M. Frates

Location
Cambridge, MA
Summary
The estimated net worth of James M. Frates is at least $4.22M dollars as of October 2, 2025. James M. Frates is the Chief Financial Officer of Amylyx Pharmaceuticals, Inc. and owns shares of Amylyx Pharmaceuticals, Inc. (AMLX) stock worth about $4.22M.
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
All Insider Reports
All Insider Reports

Notify me when James M. Frates files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of James M. Frates

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AMLX Amylyx Pharmaceuticals, Inc. Chief Financial Officer $4.22M -$192K -4.37% Sep 30, 2025
SAGE Sage Therapeutics, Inc. Director $0 Jul 31, 2025

Insider Transactions Reported by James M. Frates:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.